Catubig, Baby Boy .
HRN: 22-13-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2022
AMPICILLIN 1GM (VIAL)
10/29/2022
11/04/2022
IV
95mg
Q12
PSNB
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes